Companies:64525
FatCapitalist:Apple Inc. [AAPL]United States

Catalyst Pharmaceuticals, Inc. [CPRXUnited States

NasdaqCM exchange. Sector: Healthcare. Industry: Biotechnology. Location United States, Coral Gables.
At close Fri Sep 30 2022
12.83 USD 👍0.42 (+3.27%)

At close Fri Sep 30 2022

Marketcap
1,323,003,904 USD

Marketcap

PE:18.070
BETA (5y):1.263
EPS:0.710
Profits

for 5 years

960%

for 3 years

371%

for 2 years

189%

for 1 year

226%

for this year

106%
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.

Catalyst Pharmaceuticals, Inc.
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.